199 related articles for article (PubMed ID: 2139075)
1. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.
Maliszewski CR; Sato TA; Vanden Bos T; Waugh S; Dower SK; Slack J; Beckmann MP; Grabstein KH
J Immunol; 1990 Apr; 144(8):3028-33. PubMed ID: 2139075
[TBL] [Abstract][Full Text] [Related]
2. Induction of B cell activities by interleukin 4 is inhibited by a receptor-specific monoclonal antibody in vitro.
Maliszewski CR; Sato TA; Vanden Bos T; Beckmann MP; Grabstein KH
Eur J Immunol; 1990 Aug; 20(8):1735-40. PubMed ID: 2145164
[TBL] [Abstract][Full Text] [Related]
3. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor.
Fanslow WC; Clifford KN; Park LS; Rubin AS; Voice RF; Beckmann MP; Widmer MB
J Immunol; 1991 Jul; 147(2):535-40. PubMed ID: 1830065
[TBL] [Abstract][Full Text] [Related]
4. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo.
Sato TA; Widmer MB; Finkelman FD; Madani H; Jacobs CA; Grabstein KH; Maliszewski CR
J Immunol; 1993 Apr; 150(7):2717-23. PubMed ID: 8454851
[TBL] [Abstract][Full Text] [Related]
5. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4.
Chilton PM; Fernandez-Botran R
J Immunol; 1993 Dec; 151(11):5907-17. PubMed ID: 8245438
[TBL] [Abstract][Full Text] [Related]
6. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
[TBL] [Abstract][Full Text] [Related]
8. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
[TBL] [Abstract][Full Text] [Related]
9. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes.
Garrone P; Djossou O; Galizzi JP; Banchereau J
Eur J Immunol; 1991 Jun; 21(6):1365-9. PubMed ID: 1828424
[TBL] [Abstract][Full Text] [Related]
10. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor.
Blum H; Wolf M; Enssle K; Röllinghoff M; Gessner A
J Immunol; 1996 Sep; 157(5):1846-53. PubMed ID: 8757301
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
König B; Fischer A; König W
Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156
[TBL] [Abstract][Full Text] [Related]
12. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
13. B cell activator. Effects on B cell expression of CD23, proliferation, and antibody secretion.
Marcelletti JF; Matsushita S; Katz DH
J Immunol; 1992 Jun; 148(12):3857-63. PubMed ID: 1318334
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4.
Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P
J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation.
Zuber CE; Galizzi JP; Vallé A; Harada N; Howard M; Banchereau J
Eur J Immunol; 1990 Mar; 20(3):551-5. PubMed ID: 2318249
[TBL] [Abstract][Full Text] [Related]
16. Expression of B cell surface receptors. II. IL-4 can accelerate the developmental expression of the murine B cell IgE Fc receptor.
Waldschmidt TJ; Conrad DH; Lynch RG
J Immunol; 1989 Nov; 143(9):2820-7. PubMed ID: 2530279
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
Nasert S; Millner M; Herz U; Lack G; Wahn U; Gelfand EW; Renz H
Behring Inst Mitt; 1995 Jun; (96):118-30. PubMed ID: 7575347
[TBL] [Abstract][Full Text] [Related]
18. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes.
Finkelman FD; Madden KB; Morris SC; Holmes JM; Boiani N; Katona IM; Maliszewski CR
J Immunol; 1993 Aug; 151(3):1235-44. PubMed ID: 8393043
[TBL] [Abstract][Full Text] [Related]
19. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis.
Fernandez-Botran R; Wynn TA; Hieny S; Caspar P; Chilton PM; Sher A
Eur J Immunol; 1995 Mar; 25(3):649-56. PubMed ID: 7705393
[TBL] [Abstract][Full Text] [Related]
20. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset.
Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE
Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
